Interestingly, sPD-L1 levels do not always correlate with tumor PD-L1 expression as assessed by immunohistochemistry, highlighting the possibility that the circulating form may be regulated independently or produced by non-malignant stromal and immune cells within the tumor microenvironment [53]. This evidence concerns the gene CD274 and neoplasm.